Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CTMX - CytomX: A Fresh Start With New Drugs After Total Pipeline Failure

CTMX - CytomX: A Fresh Start With New Drugs After Total Pipeline Failure

CytomX Therapeutics Inc.

2025-10-06 11:20:56 ET

Introduction

My 2018 rating on CytomX Therapeutics ( CTMX ) was buy with hopes that its "Probody therapeutic technology" would bear fruit amid a “pretty high” valuation. After a few years of clinical trial failures, CTMX has since cratered 87%, compared to index ( SPY ) returns of 146% during the same period....

For further details see:

CytomX: A Fresh Start With New Drugs After Total Pipeline Failure

Stock Information
Company Name: CytomX Therapeutics Inc.
Stock Symbol: CTMX
Market: NASDAQ
Website: cytomx.com
Menu
Get CTMX Alerts

News, Short Squeeze, Breakout and More Instantly...